Biliary Dyskinesia

A functional gallbladder disorder characterized by biliary-type pain without gallstones, diagnosed by reduced gallbladder ejection fraction (<35-40%) on cholecystokinin-stimulated cholescintigraphy. May benefit from cholecystectomy.

Quick Answer

What it is

A functional gallbladder disorder characterized by biliary-type pain without gallstones, diagnosed by reduced gallbladder ejection fraction (<35-40%) on cholecystokinin-stimulated cholescintigraphy. May benefit from cholecystectomy.

Key findings

  • Grade A: Gallbladder Ejection Fraction (Sincalide (Kinevac))
  • Grade A: Gallbladder Contraction (Sincalide (Kinevac))
  • Grade B: Surgical Outcome Prediction (Sincalide (Kinevac))

Safety

No specific caution or interaction language was detected in the current summary/outcome notes.

ℹ️ Quick Facts

Quick Facts: Biliary Dyskinesia

  • Supplements Studied:1
1 supps · 3 outcomes

Detailed Outcomes

A
Gallbladder Ejection Fraction
Standard 60-min sincalide infusion establishes GBEF normal values. Lower limit of normal: 38% at 1% CI. GBEF <35-40% indicates gallbladder dysfunction. Coefficient of variation 19% for 60-min protocol.
largeImproves
A
Gallbladder Contraction
Reduces gallbladder radiographic size by ≥40% in normal patients. Enables visualization of gallbladder function via cholescintigraphy. Gold standard for acalculous cholecystitis diagnosis.
largeImproves
B
Surgical Outcome Prediction
81.4% complete symptom resolution after cholecystectomy in low GBEF patients. Systematic review of 1,710 patients. GBEF alone may not reliably predict outcomes; other factors contribute.
moderateImproves

Research Citations (29)

Gastrointestinal cholecystokinin signaling pathway drugs modulate osteogenic/cementogenic differentiation of human periodontal ligament stem cells.
(2025)
PMID: 40032153
Ojeok-san enhances platinum sensitivity in ovarian cancer by regulating adipocyte paracrine IGF1 secretion.
(2024)
PMID: 37993991
HDAC1-Mediated Downregulation of NEU1 Exacerbates the Aggressiveness of Cervical Cancer.
(2024)
PMID: 38505872
Defining Biliary Hyperkinesia and the Role of Cholecystectomy
(2023)
PMID: 37366537
C1QTNF6 Targeted by MiR-184 Regulates the Proliferation, Migration, and Invasion of Lung Adenocarcinoma Cells.
(2022)
PMID: 35578071
Cholescintigraphy may have a role in selecting patients with biliary dyskinesia for cholecystectomy: a systematic review
(2020)
PMID: 32479706
Utilizing the Cholecystagogue, Ensure Plus, Results in Similar Hepatobiliary Scintigraphy Study Results and Patient Outcomes Status Post Cholecystectomy, in Comparison With Sincalide.
(2020)
PMID: 31789906
Sincalide: A Review of Clinical Utility, Proper Infusion Methodology, and Alternative Cholecystogogues.
(2019)
PMID: 31019045
Endoscopic Pancreatic Function Test using Combined Secretin and Cholecystokinin Stimulation for the Evaluation of Chronic Pancreatitis
(2015)
PMID: 25773097
Pain provocation and low gallbladder ejection fraction with CCK cholescintigraphy are not predictive of chronic acalculous gallbladder disease symptom relief after cholecystectomy
(2014)
PMID: 24852884

Related Conditions